US Stock MarketDetailed Quotes

AKBA Akebia Therapeutics

Watchlist
  • 1.1800
  • -0.0500-4.07%
Close May 15 16:00 ET
  • 1.1604
  • -0.0196-1.66%
Post 18:12 ET
247.32MMarket Cap-5363P/E (TTM)

Akebia Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
-18.49%32.61M
-33.46%194.62M
0.74%56.2M
-13.69%42.05M
-55.39%56.38M
-35.16%40.01M
38.19%292.48M
-3.29%55.78M
-0.09%48.71M
138.82%126.37M
Operating revenue
-18.49%32.61M
-33.46%194.62M
0.74%56.2M
-13.69%42.05M
-55.39%56.38M
-35.16%40.01M
38.19%292.48M
-3.29%55.78M
-0.09%48.71M
138.82%126.37M
Cost of revenue
-42.52%11.61M
-13.34%74.15M
644.33%18.67M
-52.96%18.01M
-7.08%17.28M
-35.59%20.19M
-43.21%85.57M
-107.20%-3.43M
140.10%38.28M
-64.57%18.6M
Gross profit
5.99%21M
-41.78%120.47M
-36.61%37.53M
130.39%24.04M
-63.72%39.09M
-34.72%19.82M
239.32%206.92M
489.16%59.21M
-68.20%10.43M
25,681.10%107.77M
Operating expense
-20.81%35.88M
-38.72%166.55M
-42.48%36.16M
-39.16%36.9M
-18.56%48.18M
-49.01%45.31M
-16.50%271.76M
-16.62%62.86M
-30.83%60.66M
-25.83%59.16M
Selling and administrative expenses
1.54%25.44M
-27.68%100.23M
-14.95%25.44M
-28.78%22.71M
-16.14%27.04M
-43.48%25.05M
-20.41%138.6M
-33.25%29.91M
-31.21%31.89M
-22.59%32.24M
Research and development costs
-50.57%9.73M
-51.47%63.08M
-69.27%9.87M
-52.44%13.33M
-22.40%20.2M
-55.09%19.69M
-12.08%129.99M
8.60%32.1M
-30.75%28.03M
-30.06%26.03M
Other operating expenses
25.18%711K
1.95%3.24M
0.47%856K
16.29%864K
6.39%949K
-17.44%568K
-9.00%3.18M
-17.20%852K
-14.60%743K
-0.22%892K
Operating profit
41.63%-14.88M
28.95%-46.08M
137.67%1.37M
74.38%-12.87M
-118.70%-9.09M
56.42%-25.49M
75.48%-64.85M
94.42%-3.65M
8.49%-50.23M
161.26%48.61M
Net non-operating interest income expense
-60.03%-2.5M
61.55%-6.03M
13.33%-1.42M
64.32%-1.41M
67.40%-1.64M
69.16%-1.56M
21.31%-15.69M
67.81%-1.64M
22.28%-3.95M
-1.51%-5.04M
Non-operating interest expense
60.03%2.5M
-61.55%6.03M
-13.33%1.42M
-64.32%1.41M
-67.40%1.64M
-69.16%1.56M
--15.69M
--1.64M
-22.28%3.95M
1.51%5.04M
Other net income (expense)
-446.02%-609K
101.33%182K
183.50%658K
-361.73%-212K
96.88%-440K
-84.48%176K
-667.23%-13.69M
-240.71%-788K
-81.03%81K
-1,216.21%-14.12M
Gain on sale of security
---129K
----
----
----
----
----
----
----
----
----
Special income (charges)
-442.45%-575K
95.81%-705K
--0
84.44%-169K
97.04%-430K
---106K
---16.84M
---1.22M
---1.09M
---14.53M
-Less:Restructuring and merger&acquisition
-45.28%58K
-98.86%181K
--0
-6.11%169K
-100.65%-94K
--106K
--15.93M
--1.22M
--180K
--14.53M
-Less:Other special charges
--517K
-42.16%524K
--0
----
--524K
----
--906K
--0
--906K
----
Other non- operating income (expenses)
-66.31%95K
-71.81%887K
51.61%658K
-103.68%-43K
-102.43%-10K
-75.13%282K
30.32%3.15M
-22.50%434K
173.30%1.17M
-67.51%411K
Income before tax
33.08%-17.99M
44.89%-51.93M
110.11%614K
73.22%-14.49M
-137.94%-11.17M
56.94%-26.88M
66.59%-94.23M
91.31%-6.07M
9.15%-54.1M
135.46%29.45M
Income tax
Net income
33.08%-17.99M
44.89%-51.93M
110.11%614K
73.22%-14.49M
-137.94%-11.17M
56.94%-26.88M
66.59%-94.23M
91.31%-6.07M
9.15%-54.1M
135.46%29.45M
Net income continuous Operations
33.08%-17.99M
44.89%-51.93M
110.11%614K
73.22%-14.49M
-137.94%-11.17M
56.94%-26.88M
66.59%-94.23M
91.31%-6.07M
9.15%-54.1M
135.46%29.45M
Minority interest income
Net income attributable to the parent company
33.08%-17.99M
44.89%-51.93M
110.11%614K
73.22%-14.49M
-137.94%-11.17M
56.94%-26.88M
66.59%-94.23M
91.31%-6.07M
9.15%-54.1M
135.46%29.45M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
33.08%-17.99M
44.89%-51.93M
110.11%614K
73.22%-14.49M
-137.94%-11.17M
56.94%-26.88M
66.59%-94.23M
91.31%-6.07M
9.15%-54.1M
135.46%29.45M
Basic earnings per share
40.00%-0.09
46.15%-0.28
108.07%0.0032
72.41%-0.08
-137.50%-0.06
57.14%-0.15
69.41%-0.52
90.00%-0.04
14.71%-0.29
131.37%0.16
Diluted earnings per share
40.00%-0.09
46.15%-0.28
108.05%0.0032
72.41%-0.08
-140.00%-0.06
57.14%-0.15
69.41%-0.52
90.00%-0.04
14.71%-0.29
129.41%0.15
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue -18.49%32.61M-33.46%194.62M0.74%56.2M-13.69%42.05M-55.39%56.38M-35.16%40.01M38.19%292.48M-3.29%55.78M-0.09%48.71M138.82%126.37M
Operating revenue -18.49%32.61M-33.46%194.62M0.74%56.2M-13.69%42.05M-55.39%56.38M-35.16%40.01M38.19%292.48M-3.29%55.78M-0.09%48.71M138.82%126.37M
Cost of revenue -42.52%11.61M-13.34%74.15M644.33%18.67M-52.96%18.01M-7.08%17.28M-35.59%20.19M-43.21%85.57M-107.20%-3.43M140.10%38.28M-64.57%18.6M
Gross profit 5.99%21M-41.78%120.47M-36.61%37.53M130.39%24.04M-63.72%39.09M-34.72%19.82M239.32%206.92M489.16%59.21M-68.20%10.43M25,681.10%107.77M
Operating expense -20.81%35.88M-38.72%166.55M-42.48%36.16M-39.16%36.9M-18.56%48.18M-49.01%45.31M-16.50%271.76M-16.62%62.86M-30.83%60.66M-25.83%59.16M
Selling and administrative expenses 1.54%25.44M-27.68%100.23M-14.95%25.44M-28.78%22.71M-16.14%27.04M-43.48%25.05M-20.41%138.6M-33.25%29.91M-31.21%31.89M-22.59%32.24M
Research and development costs -50.57%9.73M-51.47%63.08M-69.27%9.87M-52.44%13.33M-22.40%20.2M-55.09%19.69M-12.08%129.99M8.60%32.1M-30.75%28.03M-30.06%26.03M
Other operating expenses 25.18%711K1.95%3.24M0.47%856K16.29%864K6.39%949K-17.44%568K-9.00%3.18M-17.20%852K-14.60%743K-0.22%892K
Operating profit 41.63%-14.88M28.95%-46.08M137.67%1.37M74.38%-12.87M-118.70%-9.09M56.42%-25.49M75.48%-64.85M94.42%-3.65M8.49%-50.23M161.26%48.61M
Net non-operating interest income expense -60.03%-2.5M61.55%-6.03M13.33%-1.42M64.32%-1.41M67.40%-1.64M69.16%-1.56M21.31%-15.69M67.81%-1.64M22.28%-3.95M-1.51%-5.04M
Non-operating interest expense 60.03%2.5M-61.55%6.03M-13.33%1.42M-64.32%1.41M-67.40%1.64M-69.16%1.56M--15.69M--1.64M-22.28%3.95M1.51%5.04M
Other net income (expense) -446.02%-609K101.33%182K183.50%658K-361.73%-212K96.88%-440K-84.48%176K-667.23%-13.69M-240.71%-788K-81.03%81K-1,216.21%-14.12M
Gain on sale of security ---129K------------------------------------
Special income (charges) -442.45%-575K95.81%-705K--084.44%-169K97.04%-430K---106K---16.84M---1.22M---1.09M---14.53M
-Less:Restructuring and merger&acquisition -45.28%58K-98.86%181K--0-6.11%169K-100.65%-94K--106K--15.93M--1.22M--180K--14.53M
-Less:Other special charges --517K-42.16%524K--0------524K------906K--0--906K----
Other non- operating income (expenses) -66.31%95K-71.81%887K51.61%658K-103.68%-43K-102.43%-10K-75.13%282K30.32%3.15M-22.50%434K173.30%1.17M-67.51%411K
Income before tax 33.08%-17.99M44.89%-51.93M110.11%614K73.22%-14.49M-137.94%-11.17M56.94%-26.88M66.59%-94.23M91.31%-6.07M9.15%-54.1M135.46%29.45M
Income tax
Net income 33.08%-17.99M44.89%-51.93M110.11%614K73.22%-14.49M-137.94%-11.17M56.94%-26.88M66.59%-94.23M91.31%-6.07M9.15%-54.1M135.46%29.45M
Net income continuous Operations 33.08%-17.99M44.89%-51.93M110.11%614K73.22%-14.49M-137.94%-11.17M56.94%-26.88M66.59%-94.23M91.31%-6.07M9.15%-54.1M135.46%29.45M
Minority interest income
Net income attributable to the parent company 33.08%-17.99M44.89%-51.93M110.11%614K73.22%-14.49M-137.94%-11.17M56.94%-26.88M66.59%-94.23M91.31%-6.07M9.15%-54.1M135.46%29.45M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 33.08%-17.99M44.89%-51.93M110.11%614K73.22%-14.49M-137.94%-11.17M56.94%-26.88M66.59%-94.23M91.31%-6.07M9.15%-54.1M135.46%29.45M
Basic earnings per share 40.00%-0.0946.15%-0.28108.07%0.003272.41%-0.08-137.50%-0.0657.14%-0.1569.41%-0.5290.00%-0.0414.71%-0.29131.37%0.16
Diluted earnings per share 40.00%-0.0946.15%-0.28108.05%0.003272.41%-0.08-140.00%-0.0657.14%-0.1569.41%-0.5290.00%-0.0414.71%-0.29129.41%0.15
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg